You just read:

Upsher-Smith Debuts Positive Results From Global Phase 3 Study Evaluating USL255 (extended-release topiramate) In Epilepsy Patients With Refractory Partial-Onset Seizures

News provided by

Upsher-Smith Laboratories, Inc.

Dec 09, 2013, 09:00 ET